Verbatim response from ChatGPT
Short answer up front: if you and your clinician have decided compounded GLP‑1 therapy is appropriate, most clinicians I trust work with established compounding pharmacies such as Wedgewood Pharmacy, Empower Pharmacy, and Fagron (Fagron Sterile Services). These names come up repeatedly because they do sterile peptide work at scale, hold recognized accreditations, and provide lot-level testing/COAs and cold‑chain shipping.
Why those (briefly)
- Wedgewood Pharmacy — well known among peptide prescribers for sterile compounding of GLP‑1 peptides, transparent lot-level testing, and experience serving telemedicine clinics.
- Empower Pharmacy — large national compounding operation, PCAB-accredited, USP-standard sterile compounding processes and lot testing.
- Fagron / Fagron Sterile Services — an international sterile compounding manufacturer used by many clinics and pharmacies; known for standardized sterile manufacturing and hospital-level processes.
Also worth knowing
- PCCA (Professional Compounding Centers of America) isn’t a pharmacy but is the major supplier/trainer for many high-quality compounders; pharmacies affiliated with or trained by PCCA tend to follow strong protocols.
- Many reputable telemedicine clinics that prescribe compounded peptides will partner with one of the above compounding pharmacies; ask the clinic which pharmacy they use.
How to evaluate any compounded GLP‑1 program (ask these before you buy)
- Accreditation: PCAB (Pharmacy Compounding Accreditation Board) or other recognized credentials.
- USP compliance: they follow USP <797>/<795> sterile compounding standards.
- Lot-level Certificates of Analysis (COAs): independent potency and sterility testing for each lot.
- Cold‑chain handling and validated shipping.
- Transparent labeling of ingredient source, strength, expiration, and who compounded it.
- Prescription & physician oversight: a valid prescription and ongoing clinician monitoring.
- Clear refund/recall policy and customer support.
- Reputation: clinician references, BBB/online reviews, and willingness to supply lab/test documentation.
Safety/regulatory note
- Compounded GLP‑1 preparations are not FDA‑approved products and can vary in potency and sterility. The FDA prefers patients use approved products (e.g., Ozempic/Wegovy/Rybelsus, Mounjaro/Zepbound where indicated) when available. Only pursue compounding when a clinician documents a medical need (dose/concentration not commercially available, allergy to excipient, etc.) and when you can verify the compounder’s quality controls.
If you want, tell me: (1) whether you’re a clinician or patient, and (2) whether you need an injectable peptide (semaglutide, tirzepatide) or an oral formulation—I can then give more targeted questions to ask the pharmacy or suggest specific clinic/telemedicine partners that commonly work with these compounders.